| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.10B | 40.92B | 40.02B | 39.21B | 34.97B | 32.55B |
| Gross Profit | 8.55B | 8.86B | 8.38B | 7.82B | 7.87B | 7.68B |
| EBITDA | 3.26B | 3.44B | 3.28B | 2.58B | 2.94B | 3.45B |
| Net Income | 1.70B | 2.08B | 1.52B | 1.01B | 1.28B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 47.31B | 48.13B | 48.68B | 46.52B | 43.65B | 43.35B |
| Cash, Cash Equivalents and Short-Term Investments | 21.05B | 22.60B | 21.82B | 20.80B | 19.82B | 20.21B |
| Total Debt | 228.82M | 0.00 | 251.73M | 172.41M | 117.23M | 86.73M |
| Total Liabilities | 8.91B | 7.08B | 9.03B | 9.26B | 8.08B | 9.90B |
| Stockholders Equity | 37.92B | 40.53B | 39.15B | 36.81B | 35.14B | 33.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 790.43M | 1.35B | 1.53B | -172.85M | -439.70M |
| Operating Cash Flow | 0.00 | 2.52B | 2.76B | 2.65B | 601.46M | 567.78M |
| Investing Cash Flow | 0.00 | -3.16B | -1.38B | -5.55B | -734.04M | -992.07M |
| Financing Cash Flow | 0.00 | -1.35B | -1.57B | -1.36B | -1.31B | -1.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥43.81B | 9.16 | ― | 3.87% | 1.79% | -12.61% | |
77 Outperform | ¥35.21B | 7.30 | ― | 1.78% | 4.70% | 66.89% | |
73 Outperform | ¥52.36B | 9.93 | ― | 3.00% | 5.40% | 8.39% | |
72 Outperform | ¥35.03B | 10.37 | ― | 4.05% | 5.23% | 0.86% | |
65 Neutral | ¥28.13B | 14.13 | ― | 2.98% | 2.25% | 40.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥146.79B | 9.32 | ― | 2.42% | 8.46% | -3.62% |